Autoimmune neuropathien - Current aspects of immunopathologic diagnostics and therapy;Immunneuropathien - Aktuelle aspekte der diagnostik und therapie

Nervenarzt

Volumn 76, Issue 8, 2005, Pages 1009-1023

  Gold, R ^a,c   Bayas, A ^b   Toyka, K V ^b  

^a Gemeinnutzige Hertie Stiftung   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c Institut für MS Forschung   (Germany)

Author keywords

Autoimmunity; Polyneuropathy; Therapy

Indexed keywords

ALPHA2A INTERFERON; AZATHIOPRINE; BETA1A INTERFERON; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; TACROLIMUS;

AUTOIMMUNE DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG EFFICACY; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LABORATORY DIAGNOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MONONEUROPATHY MULTIPLEX; NERVE BIOPSY; NEURITIS; NEUROPATHY; PLASMAPHERESIS; REVIEW;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; IMMUNOTHERAPY; PHYSICIAN'S PRACTICE PATTERNS; POLYNEUROPATHIES; PRACTICE GUIDELINES;

EID: 23944486643     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-1942-5     Document Type: Review

References (24)

1. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome [see comments]. Ann Neurol 27 [Suppl]:S21-S24
2. Comi G, Roveri L, Swan A et al. (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249:1370-1377
3. Dyck PJ, Litchy WJ, Kratz KM et al. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838-845
4. Dyck PJ, Low PA, Windebank AJ et al. (1989) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325:1482-1486
5. Gold R, Dalakas MC, Toyka KV (2003) Immunotherapy in autoimmune neuromuscular disorders. Lancet Neurol 2:22-32
6. Gold R, Fontana A, Zierz S (2003) Therapy of neurological disorders in systemic vasculitis. Semin Neurol 23:207-214
7. Gold R, Reiners K, Toyka KV (1999) Pathogenese und Behandlungsstrategien des akuten Guillain-Barre Syndroms. Nervenheilkunde 18:34-39
8. Hahn AF, Bolton CF, Pillay N et al. (1996) Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy - A double-blind, sham-controlled, cross-over study. Brain 119:1055-1066
9. Hartung HP, Pollard JD, Harvey GK et al. (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 18:137-153
10. Harvey GK, Gold R, Toyka KV et al. (1995) Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain 118:1263-1272
11. Hughes R, Bensa S, Willison H et al. (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195-201
12. Kieseier BC, Kiefer R, Gold R et al. (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131-156
13. Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3:457-465
14. Maurer M, Gold R (2002) Animal models of immune-mediated neuropathies. Curr Opin Neurol 15:617-622
15. Maurer M, Stoll G, Toyka KV (2004) Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness. Neuromuscul Disord 14:380-382
16. Nobile-Orazio E (2001) Multifocal motor neuropathy. J Neuroimmunol 115:4-18
17. Pestronk A (1998) Multifocal motor neuropathy: diagnosis and treatment. Neurology 51:S22-S24
18. Renaud S, Gregor M, Fuhr P et al. (2003) Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27:611-615
19. Saperstein DS, Katz JS, Amato AA et al. (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311-324
20. Steck AJ, Schaeren-Wiemers N, Hartung HP (1998) Demyelinating inflammatory neuropathies, including Guillain-Barre syndrome [published erratum appears in Curr Opin Neurol 1998 Dec;11(6):739]. Curr Opin Neurol 11:311-318
21. Toyka KV, Hartung HP (1996) Chronic inflammatory polyneuritis and neuropathies. Curr Opin Neurol 9:240-250
22. Van Koningsveld R, Schmitz PIM, van der Meche FGA et al. (2004) Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 363:192-196
23. Vital A (2001) Paraproteinemic neuropathies. Brain Pathol 11:399-407
24. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591-2625